A decrease in resveratrol-treated eyes has been observed in myopia-related tissue remodeling proteins and the expression of inflammatory cytokines (NFκB, TGF-β, MMP2, TNFα, IL-6, and IL-1β). This evidence concerns the gene MMP2 and myopia.